QcrB inhibition as a potential approach for the treatment of tuberculosis: A review of recent developments, patents, and future directions

• Main Authors: Mohd. Imran (Author), Abida (Author), Nawaf M. Alotaibi (Author), Hamdy K. Thabet (Author), Jamal A. Alruwaili (Author), Syed M.B. Asdaq (Author), Lina Eltaib (Author), Ahmed Alshehri (Author), Ahad A. Alsaiari (Author), Mazen Almehmadi (Author), Amal B. Hommod Alshammari (Author), Abdulmajeed M. Alshammari (Author)
• Format: Book
• Published: Elsevier, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The unmet medical need for drug-resistant tuberculosis (DRTB) is a significant concern. Accordingly, identifying new drug targets for tuberculosis (TB) treatment and developing new therapies based on these drug targets is one of the strategies to tackle DRTB. QcrB is an innovative drug target to cre...